These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 12045360

  • 1. Regulation of corticotropin-releasing factor receptor type 2beta messenger ribonucleic acid by interleukin-1beta in rat vascular smooth muscle cells.
    Kageyama K, Suda T.
    Neuroimmunomodulation; 2001; 9(6):326-32. PubMed ID: 12045360
    [Abstract] [Full Text] [Related]

  • 2. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines.
    Kageyama K, Gaudriault GE, Bradbury MJ, Vale WW.
    Endocrinology; 2000 Jul; 141(7):2285-93. PubMed ID: 10875227
    [Abstract] [Full Text] [Related]

  • 3. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K, Gaudriault GE, Suda T, Vale WW.
    Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells.
    Kageyama K, Hanada K, Nigawara T, Furukawa K, Terui K, Ogura E, Motomura S, Suda T.
    Peptides; 2007 May; 28(5):1059-67. PubMed ID: 17346851
    [Abstract] [Full Text] [Related]

  • 5. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.
    Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K.
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3031-9. PubMed ID: 11087261
    [Abstract] [Full Text] [Related]

  • 6. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
    Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N.
    Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of corticotropin-releasing hormone receptor type 2beta mRNA expression in the rat cardiovascular system following food deprivation.
    Nazarloo HP, Nishiyama M, Tanaka Y, Asaba K, Hashimoto K.
    Regul Pept; 2002 May 15; 105(2):121-9. PubMed ID: 11891012
    [Abstract] [Full Text] [Related]

  • 8. Regulation of corticotropin-releasing factor receptor type 2beta mRNA by mitogen-activated protein kinases in aortic smooth muscle cells.
    Kageyama K, Hanada K, Suda T.
    Regul Pept; 2005 Mar 30; 126(3):223-31. PubMed ID: 15664670
    [Abstract] [Full Text] [Related]

  • 9. Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells.
    Kageyama K, Hanada K, Nigawara T, Moriyama T, Terui K, Sakihara S, Suda T.
    Endocrinology; 2006 Sep 30; 147(9):4454-62. PubMed ID: 16777977
    [Abstract] [Full Text] [Related]

  • 10. Role of corticotropin-releasing factor receptor type 2 beta in urocortin-induced vasodilation of rat aortas.
    Miki I, Seya K, Motomura S, Furukawa K.
    J Pharmacol Sci; 2004 Oct 30; 96(2):170-6. PubMed ID: 15467262
    [Abstract] [Full Text] [Related]

  • 11. Urocortin stimulates tyrosine hydroxylase activity via the cAMP/protein kinase a pathway in rat Pheochromocytoma PC12 cells.
    Nanmoku T, Takekoshi K, Fukuda T, Isobe K, Shibuya S, Kawakami Y.
    Neurosci Lett; 2004 Oct 30; 382(1-2):124-7. PubMed ID: 15911134
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K, Hanada K, Moriyama T, Imaizumi T, Satoh K, Suda T.
    Mol Cell Endocrinol; 2007 Jan 15; 263(1-2):90-102. PubMed ID: 17027144
    [Abstract] [Full Text] [Related]

  • 13. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells.
    Kageyama K, Suda T.
    Endocrinology; 2003 Jun 15; 144(6):2234-41. PubMed ID: 12746280
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
    Chen A, Vaughan J, Vale WW.
    Mol Endocrinol; 2003 Aug 15; 17(8):1622-39. PubMed ID: 12764078
    [Abstract] [Full Text] [Related]

  • 15. Urocortin-induced relaxation in the human internal mammary artery.
    Chen ZW, Huang Y, Yang Q, Li X, Wei W, He GW.
    Cardiovasc Res; 2005 Mar 01; 65(4):913-20. PubMed ID: 15721872
    [Abstract] [Full Text] [Related]

  • 16. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection.
    Takao T, Hashimoto K, De Souza EB.
    Brain Behav Immun; 1995 Dec 01; 9(4):276-91. PubMed ID: 8903846
    [Abstract] [Full Text] [Related]

  • 17. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H.
    J Clin Endocrinol Metab; 2002 Jan 01; 87(1):340-6. PubMed ID: 11788672
    [Abstract] [Full Text] [Related]

  • 18. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart.
    Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E, Stenzel-Poore MP.
    Endocrinology; 2001 Aug 01; 142(8):3537-45. PubMed ID: 11459800
    [Abstract] [Full Text] [Related]

  • 19. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
    Aubry JM, Turnbull AV, Pozzoli G, Rivier C, Vale W.
    Endocrinology; 1997 Apr 01; 138(4):1621-6. PubMed ID: 9075723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.